Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-Health Disparities Subcommittee (HDS), 15611-15612 [2015-06645]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Sleep
Disorders Research Advisory Board.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Sleep Disorders
Research Advisory Board.
Date: April 29, 2015.
Time: 8:15 a.m. to 5:00 p.m.
Agenda: To discuss and provide updates
on NIH Sleep Research, the NIH Sleep
Disorders Research Plan and inter-agency
coordination activities, planning for.
Place: National Institutes of Health, Fishers
Lane Conference, Center Terrace Level, 5635
Fisher Lane, Rockville, MD 20892.
Contact Person: Michael J. Twery, Ph.D.,
Director, National Center on Sleep Disorders
Research, Division of Lung Diseases, National
Heart, Lung, and Blood Institute, National
Institutes of Health, 6701 Rockledge Drive,
Suite 10038, Bethesda, MD 20892–7952, 301–
435–0199 twerym@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: March 18, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–06600 Filed 3–23–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
VerDate Sep<11>2014
01:09 Mar 24, 2015
Jkt 235001
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10:30 a.m.–5:00 p.m.
EDT, April 14, 2015.
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public, but
without a public comment period. The
public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcome to listen to the meeting by
joining the teleconference at the USA
toll-free, dial-in number is 1–866–659–
0537 and the pass code is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and will expire on August 3, 2015.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. The
Subcommittee for Dose Reconstruction
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
15611
Reviews was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters for Discussion: The agenda for
the Subcommittee meeting includes the
following dose reconstruction program
quality management and assurance
activities: Current findings from NIOSH
and Advisory Board dose reconstruction
blind reviews; dose reconstruction cases
under review including Pacific Proving
Grounds, DuPont Deepwater Works, and
cases from Sets 14–18, including the
Oak Ridge sites (Y–12, K–25, Oak Ridge
National Laboratory, and Savannah
River Site; plans for dose reconstruction
case reviews; preparation of the
Advisory Board’s next report to the
Secretary, HHS, summarizing the results
of completed dose reconstruction
reviews.
The agenda is subject to change as
priorities dictate.
Contact Person For More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton
Road, Mailstop E–20, Atlanta, GA
30333, Telephone (513) 533–6800, Toll
Free 1 (800) CDC–INFO, Email
ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–06643 Filed 3–23–15; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—Health Disparities
Subcommittee (HDS)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 10:00 a.m.–6:00 p.m.
EDT, April 16, 2015.
E:\FR\FM\24MRN1.SGM
24MRN1
mstockstill on DSK4VPTVN1PROD with NOTICES
15612
Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices
Place: CDC, Building 19, Rooms
256/257, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 50
people. The public is welcome to
participate during the public comment
period, which is tentatively scheduled
from 5:30 to 5:45 p.m. This meeting is
also available by teleconference, please
dial (866) 763–0273 and enter code
6158968.
Purpose: The Subcommittee will
provide advice to the CDC Director
through the ACD on strategic and other
health disparities and health equity
issues and provide guidance on
opportunities for CDC.
Matters To Be Discussed: The Health
Disparities Subcommittee members will
discuss health equity in injury
prevention, progress toward the ACD,
CDC-approved Health Disparities
Subcommittee recommendations, and
updates on selected priorities of the
Health Disparities Subcommittee.
The agenda is subject to change as
priorities dictate.
Web links:
Windows Media: https://
wm.onlinevideoservice.com/CDC1.
Flash: https://
www.onlinevideoservice.com/clients/
CDC/?mount=CDC3.
If you are unable to connect using the
link, copy and paste the link into your
web browser.
Number for Technical Support: 404–
639–3737.
Contact Person For More Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600
Clifton Road NE., M/S K–77, Atlanta,
Georgia 30333, Telephone 770–488–
8343, Email: LEL1@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2015–06645 Filed 3–23–15; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
01:09 Mar 24, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–N–0797]
The Food and Drug Administration
Food Safety Modernization Act: Focus
on Implementation Strategy for
Prevention-Oriented Food Safety
Standards; Public Meeting and
Establishment of Docket
AGENCY:
Food and Drug Administration,
HHS.
Notice of public meeting and
establishment of docket.
ACTION:
The Food and Drug
Administration (FDA or we) is
announcing the establishment of a
docket to obtain comments that will
inform our development of FDA Food
Safety Modernization Act (FSMA)
implementation work plans. FDA is also
announcing a public meeting entitled
‘‘FDA Food Safety Modernization Act:
Focus on Implementation Strategy for
Prevention-Oriented Food Safety
Standards.’’ At the public meeting, we
will share our current thinking on our
operational strategy for implementation
work plans. We will also provide
interested persons an opportunity to
provide input on this operational
strategy and the risk-based industry
oversight framework that is at the core
of FSMA.
DATES: See section III, ‘‘How to
Participate in the Public Meeting’’ in the
SUPPLEMENTARY INFORMATION section of
this document for dates and times of the
public meeting, closing dates for
advance registration, requesting special
accommodations due to disability, and
information on deadlines for submitting
either electronic or written comments to
FDA’s Division of Dockets Management.
ADDRESSES: See section III, ‘‘How to
Participate in the Public Meeting’’ in the
SUPPLEMENTARY INFORMATION section of
this document.
FOR FURTHER INFORMATION CONTACT: For
questions about registering for the
meeting or to register by phone:
Courtney Treece, Planning Professionals
Ltd., 1210 West McDermott Dr., suite
111, Allen, TX 75013, 704–258–4983,
FAX: 469–854–6992, email:
ctreece@planningprofessionals.com.
For general questions about the
meeting or for special accommodations
due to a disability: Juanita Yates, Center
for Food Safety and Applied Nutrition
(HFS–009), Food and Drug
Administration, 5100 Paint Branch
Pkwy., College Park, MD 20740, 240–
402–1731, email:
Juanita.yates@fda.hhs.gov.
SUMMARY:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
SUPPLEMENTARY INFORMATION:
I. Background
The FDA Food Safety Modernization
Act (FSMA) (Pub. L. 111–353), signed
into law by President Obama on January
4, 2011, enables FDA to better protect
public health by helping to ensure the
safety and security of the food supply.
FSMA amends the Federal Food, Drug,
and Cosmetic Act to establish the
foundation of a modernized, preventionbased food safety system. Among other
things, FSMA requires FDA to issue
regulations regarding produce safety,
preventive controls for foods for
humans and animals, intentional
adulteration, the foreign supplier
verification program (FSVP), and the
FDA third-party accreditation program.
While FSMA reinforces industry’s
primary role and responsibility for food
safety, it also builds on and strengthens
FDA’s oversight role in establishing
food safety standards, fostering
compliance with those standards
through guidance and technical
assistance, and enforcing the standards
to protect public health when problems
occur. In fact, more so than ever before,
we are called upon by FSMA to play a
central leadership and operational role
in the future global food safety system.
Meeting this challenge—and
successfully implementing FSMA’s new
prevention-oriented, systems approach
to food safety—necessitates a new
strategy for how we perform our food
safety role and meet our new
responsibilities.
On May 2, 2014, we released our
‘‘Operational Strategy for Implementing
the FDA Food Safety Modernization Act
(FSMA),’’ available electronically at
https://www.fda.gov/Food/
GuidanceRegulation/FSMA/
ucm395105.htm, to guide the next phase
of FSMA implementation. The
operational strategy broadly outlines our
approach to food safety and the
operational strategy for our food safety
program and implementation of FSMA
after the rulemaking is complete. Within
the ‘‘Operational Strategy for
Implementing FSMA,’’ there is an
appendix that outlines guiding
principles for how the operational
strategy can be implemented with
respect to food and feed facilities,
produce safety standards, and import
oversight. The guiding principles
include the following: Expanding
inspection and surveillance;
administering new administrative
enforcement tools; developing guidance,
education, and technical assistance
tools; and building a preventionoriented import system.
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 80, Number 56 (Tuesday, March 24, 2015)]
[Notices]
[Pages 15611-15612]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-06645]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention--Health Disparities Subcommittee (HDS)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
subcommittee:
Time and Date: 10:00 a.m.-6:00 p.m. EDT, April 16, 2015.
[[Page 15612]]
Place: CDC, Building 19, Rooms 256/257, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 50 people. The public is
welcome to participate during the public comment period, which is
tentatively scheduled from 5:30 to 5:45 p.m. This meeting is also
available by teleconference, please dial (866) 763-0273 and enter code
6158968.
Purpose: The Subcommittee will provide advice to the CDC Director
through the ACD on strategic and other health disparities and health
equity issues and provide guidance on opportunities for CDC.
Matters To Be Discussed: The Health Disparities Subcommittee
members will discuss health equity in injury prevention, progress
toward the ACD, CDC-approved Health Disparities Subcommittee
recommendations, and updates on selected priorities of the Health
Disparities Subcommittee.
The agenda is subject to change as priorities dictate.
Web links:
Windows Media: https://wm.onlinevideoservice.com/CDC1.
Flash: https://www.onlinevideoservice.com/clients/CDC/?mount=CDC3.
If you are unable to connect using the link, copy and paste the
link into your web browser.
Number for Technical Support: 404-639-3737.
Contact Person For More Information: Leandris Liburd, Ph.D.,
M.P.H., M.A., Designated Federal Officer, Health Disparities
Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton
Road NE., M/S K-77, Atlanta, Georgia 30333, Telephone 770-488-8343,
Email: LEL1@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 2015-06645 Filed 3-23-15; 8:45 am]
BILLING CODE 4163-18-P
